A baboon was immunized with NP-4, a murine monoclonal antibody (MAb) to carcinoembryonic antigen (CEA). Antiidiotype antibodies were purified from the baboon serum by affinity chromatography on a NP-+coupled matrix, followed by adsorption of the non-specific antibodies on an irrelevant MAb. Baboon a
Mimicry of a carcinoembryonic antigen epitope by a rat monoclonal anti-idiotype antibody
✍ Scribed by Michele J. Losman; Kristine E. Novick; David M. Goldenberg; Marc Monestier
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- French
- Weight
- 730 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Anti‐idiotype antibodies (Ab2) that immunologically mimic tumor antigens are auspicious agents for the active immunization of cancer patients. We have developed W12, a rat monoclonal IgG~1~ Ab2 to MN ‐14, a murine anti‐carcinoembryonic antigen (CEA) monoclonal antibody. W12 is specific for MN‐14 and does not react with other isotype‐matched anti‐CEA monoclonal antibodies. Moreover, W12 inhibits the binding between MN‐14 and CEA. Anti‐CEA antibodies can be induced by immunization with W12 (but not with control rat IgG) in xenogenic animals (mice or rabbits). Immunoblotting studies indicate that the internal image determinant borne by W12 is conformational and requires the association of the heavy and light chains of the Ab2 molecule. This study indicates that W12 is a potential idiotype vaccine in patients with CEA‐producing cancers.
📜 SIMILAR VOLUMES
## Abstract In order to analyze the epitope structure of carcinoembryonic antigen (CEA) and the idiotype network system, seven anti‐idiotypic monoclonal antibodies (anti‐Id MoAbs) were generated from a BALB/c mouse immunized with anti‐CEA MoAb P1‐356, which recognized a synthetic peptide P1 of CEA,
## Abstract The distribution of a rat yolk‐sac antigen (Rat YSA‐1) as defined by a monoclonal antibody raised against rat yolksac carcinoma cells is described. The antigen is present on rat yolk‐sac carcinomas, on visceral yolk‐sac endoderm and on embryonal endoderm of 9‐day‐old embryos. It is not
## Abstract Removal of blood group anti‐A and anti‐B antibodies can prevent hyperacute organ rejection in ABO‐incompatible transplantation. We are developing an extracorporeal‐specific antibody filter (SAF) as an immunoadsorption device for direct removal of ABO blood group antibodies from whole bl